{
    "clinical_study": {
        "@rank": "62161", 
        "arm_group": [
            {
                "arm_group_label": "contrast ultrasound for patients with AAA", 
                "arm_group_type": "Active Comparator", 
                "description": "Contrast ultrasound"
            }, 
            {
                "arm_group_label": "contrast ultrasound for patients without arterial disease", 
                "arm_group_type": "Active Comparator", 
                "description": "contrast enhanced ultrasound"
            }
        ], 
        "brief_summary": {
            "textblock": "The goal is to non-invasively study the metabolic processes within the aortic wall that are\n      thought to explain progression to clinical manifestations of an aortic aneurysm.\n\n      Hypothesis is that the non-invasive imaging of Abdominal Aortic Aneurysm (AAA) with contrast\n      ultrasound, coupled with serum biomarker measurements will allow the identification of the\n      vulnerable aortic wall and patients who are at risk of AAA growth or rupture."
        }, 
        "brief_title": "Evaluation of Predictors of Aortic Aneurysm Growth and Rupture", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Abdominal Aortic Aneurysm", 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Aortic Aneurysm", 
                "Aortic Aneurysm, Abdominal", 
                "Rupture"
            ]
        }, 
        "detailed_description": {
            "textblock": "Aim#1: Prospective Contrast Ultrasound (CUS) imaging of patients with AAA to predict AAA\n      growth and test gender differences in rate of growth and rupture.\n\n      Aim#2: Serum biomarker testing of patient with AAA. CUS findings will be correlated with\n      serum biomarkers and AAA wall histology.\n\n      Prospective Contrast Ultrasound imaging of patients with AAA as part of a pilot feasibility\n      study to predict AAA growth and test gender differences in rate of growth and rupture.  CUS\n      findings will be correlated with serum biomarkers and AAA wall histology.  Potential\n      significance:  This study will evaluate the AAA wall and will be based on detecting areas of\n      increased vasa vasorum density within the aneurysm wall and intraluminal thrombus, which\n      indicate regional ischemia and inflammation of the aortic wall and propensity for weakening,\n      enlargement or rupture.  This novel evaluation of the aortic wall in patients with AAA will\n      allow individualized treatment based on the biological potential for growth and rupture."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of AAA with confirmation of diagnosis of any size aneurysm with imaging.\n\n          -  21 years of age or older\n\n          -  ability to give informed consent.\n\n        Exclusion Criteria:\n\n          -  Inability to provide an informed consent\n\n          -  Known allergy to Definity\n\n          -  Unstable cardiopulmonary conditions\n\n          -  pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "145", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02022436", 
            "org_study_id": "AG042352-01", 
            "secondary_id": "1R03AG042352-01"
        }, 
        "intervention": {
            "arm_group_label": [
                "contrast ultrasound for patients with AAA", 
                "contrast ultrasound for patients without arterial disease"
            ], 
            "intervention_name": "contrast ultrasound", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 20, 2013", 
        "location": {
            "contact": {
                "email": "brimmeierj@upmc.edu", 
                "last_name": "Brimmeier, BSN", 
                "phone": "412-235-1304"
            }, 
            "facility": {
                "address": {
                    "city": "Pittsburgh", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "15232"
                }, 
                "name": "University of Pittsburgh Medical Center, Division of Vascular Surgery"
            }, 
            "investigator": [
                {
                    "last_name": "Rabih Chaer, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Michel Makaroun, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Geetha Jeyabalan, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Edith Tzeng, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Steven Leers, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Luke Marone, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Bryan Tillman, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Timothy Wu, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ashraf Taha, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Aortic Wall Behavior as a Predictor of Aortic Aneurysm Growth and Rupture", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Prospective contrast ultrasound will be performed at regular clinically indicated timepoints.", 
            "measure": "Time to Growth and/or Rupture of abdominal aortic aneurysm.", 
            "safety_issue": "No", 
            "time_frame": "Up to 5 years or time of aneurysm repair surgery."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02022436"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Pittsburgh", 
            "investigator_full_name": "Rabih A. Chaer", 
            "investigator_title": "Associate Professor of Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Serum markers will be drawn at each follow up visit until if/when AAA is repaired.  They will also be measured 1 year after repair.", 
            "measure": "Systemic serum biomarkers of AAA will be measured.  These markers are circulating levels of Vascular Endothelial Growth Factor, C Reactive Protein, cytokines and osteoprotegerin.", 
            "safety_issue": "No", 
            "time_frame": "At the time of contrast ultrasound"
        }, 
        "source": "University of Pittsburgh", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Aging (NIA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Pittsburgh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}